Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D3 add-on to telaprevir triple therapy in treatment-naive hepatitis C
NCT01890772Phase 3Withdrawn
- Start
- Aug 2013
- Primary completion
- Oct 2015
- Countries
- 1
01
Overview
A Phase 3 trial of vitamin d in hepatitis C (HCV). Planned start Aug 2013; status: withdrawn.
02
Drugs
vitamin d
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01890772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01890772.